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Abstract
Background: Children born to parents with a severe mental illness, like schizophrenia, bipolar disorder, or major
recurrent depression, have an increased risk of developing a mental illness themselves during life. These children
are also more likely to have developmental delays, cognitive disabilities, or social problems, and they may have a
higher risk than the background population of experiencing adverse life events. This is due to both genetic and
environmental factors, but despite the well-documented increased risk for children with a familial high risk, no
family-based early intervention has been developed for them. This study aims to investigate the effect of an early
intervention that focuses on reducing risk and increasing resilience for children in families where at least one
parent has a severe mental illness.
Methods/design: The study is a randomized clinical trial with 100 children aged 6–12 with familial high risk. It is
performed in the context of the Danish health-care system. Families will be recruited from registers or be referred from
the primary sector or hospitals. The children and their parents will be assessed at baseline and thereafter randomized
and allocated to either treatment as usual or VIA Family. The intervention group will be assigned to a multidisciplinary
team of specialists from adult mental health services, child and adolescent mental health services, and social services.
This team will provide the basic treatment elements: case management, psychoeducation for the whole family,
parental training, a safety plan, and potentially an early intervention if the child has mental problems. The study
period is 18 months for both groups, and all participants will be assessed at baseline and after 18 months.
The primary outcome measure will be daily functioning of the child, and the secondary measures are the
psychopathology of the child, days of absence from school, family functioning, child’s home environment, and
parental stress.
Discussion: This study is to our knowledge the first to explore the effects of a multidisciplinary team intervention
that provides an intensive and flexible support to match the families’ needs for children with a familial high risk
for severe mental illness. The study will provide important knowledge about the potential for increasing resilience
and reducing risk for children by supporting the whole family. However, a longer follow-up period may be needed.
Trial registration: ClinicalTrials.gov, NCT03497663. Registered on 13 April 2018.
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Background
Children born to parents with a severe mental illness
(SMI), such as schizophrenia spectrum disorders, bipolar
affective disorder, or major recurrent depression, are a
group of familial high-risk children overlooked by the
mental health service system and the social services of
their municipality [1–3]. Research shows that these chil-
dren are vulnerable biologically, genetically, as well as so-
cially, and that they have an increased risk of developing a
mental illness themselves [4]. More than half of them will
at some point in life develop a mental illness and about
one third will develop an SMI.
In the mental health service system, there is a growing
awareness of the need to develop preventive strategies as
an early intervention for mental illness. However, few
concrete ideas have been identified and investigated. An
early intervention for children with a familial high-risk
of SMI could consist of providing better resources to the
family, and psychoeducation and parental training—all
initiatives that are supposed to strengthen the normal
and healthy development of the child and prevent later
mental illness. This strategy is widely recommended in
the international literature [5, 6].
High-risk studies and early risk factors
Over recent decades, several familial high-risk studies,
i.e., cohort studies of individuals born to parents with
SMI, have been conducted. These studies have docu-
mented that the increased risk of developing mental ill-
ness is caused by complex interactions between genetic
and environmental factors [7–9]. This has especially
been shown for schizophrenia [10–13], but also for
affective disorders, i.e., bipolar disorder [14, 15], and
major recurrent depression [16]. There is growing evi-
dence that on a group level, these three diagnostically
different disorders have a considerable phenomeno-
logical, biological, and genetic overlap [4, 17] . Research
has also shown that children born to parents with an
SMI more often display a series of the early signs of
mental vulnerability or delayed or disturbed develop-
ment during childhood [18–20]. These signs are under-
stood as early risk factors for the development of a mental
illness later in life. Prenatal risk factors include infections
during pregnancy, unwanted pregnancy, stress and trauma
during pregnancy, and obstetric complications [5, 21]. Ex-
amples of risk factors during childhood are different kinds
of childhood traumas such as child neglect, physical abuse,
emotional abuse, sexual abuse, and bullying [22]—all of
which may have a serious, negative impact on child devel-
opment [5, 23]. Moreover, there are a number of social
early risk factors, such as having a mother diagnosed with
schizophrenia, which may increase the risk of living in a
dysfunctional family [23], with a single parent [24] or a par-
ent with poor parenting skills [25], or in poor
socioeconomic conditions [26]. It is important to mention
that some children of parents with an SMI will not be influ-
enced by these risk factors, while others will be affected by
several.
Neurodevelopmental perspective
Studies have shown that familial high-risk children born
to parents with an SMI are vulnerable in several aspects
[27–31]. Familial high-risk children are more likely to
have unspecific mental health problems like anxiety, aut-
ism spectrum symptoms, or subtle psychosis-like symp-
toms called psychotic-like experiences, such as brief or
transient hallucinations or delusion-like convictions.
They may also show delayed motor or language develop-
ment or cognitive disabilities, like attention deficits or
problems with working memory or impulse control [10,
27, 32–34]. Furthermore, behavioral patterns, like poor
emotional regulation (i.e., the ability to regulate and
adapt emotions and impulses to the given situation)
[35], affective control [36], or social adaptation, may also
be affected in familial high-risk children [5, 19].
This increased mental vulnerability of the children is
best understood from a neurodevelopmental perspec-
tive, which is to say that the child’s normal develop-
mental process is influenced by interacting aspects of
genetic disposition and environmental factors broadly
speaking, including, for example, insufficient parental
support and stimulation, increased risk of childhood
trauma, unstable living conditions, and poor social
status [7, 23].
Mental illness can, thus, be understood as neurodeve-
lopmental deviations that start very early in life and are
influenced by risk factors as well as resilience factors
throughout the individual’s life [21, 37, 38].
Parental perspective
Parents with an SMI often lack resources in several as-
pects of life—material, financial, psychological, or social. It
can, for some, be a very demanding task to provide their
children with the necessary level and amount of support,
care, and stimulation [39]. Further, they may not always
have the energy or overview to navigate the complicated
public health system and social services, so that the
provision of help or support may be uncoordinated or
random. The level of conflicts and disagreement in the
families may be high and access to resilience-providing
factors, like sound social relations or leisure activities, may
be limited. Some children are overinvolved in their par-
ent’s symptoms, such as delusions, hallucinations, or nega-
tive and depressive symptoms, which sometimes leads to
over-responsible children, also called young carers, i.e.,
children doing tasks that should be done by an adult [40].
All these factors may increase the child’s risk of develop-
ing a mental illness later in life [41, 42].
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However, it is important also to mention that parents
who, at some time in their life, have suffered from an
SMI can do very well in terms of parenting, especially if
relevant and specialized support is available [43].
Early preventive interventions
This evidence has led to increased interest in investigat-
ing the potential of intervening at an early stage, i.e.,
before the child is diagnosed with a mental illness for
the first time or before the problems get too big and
complex. This is widely recommended in the inter-
national research literature but has been tested system-
atically only in a very few instances and not before in
Denmark [5, 6]. The hypothesis is that by providing a
very early intervention it will be possible to protect the
most vulnerable individuals against the known risk fac-
tors (e.g., childhood trauma or some of the conse-
quences of cognitive disabilities) and strengthen the
individual’s resilience by enhancing protective factors
(e.g., social relations or recreational activities). This
very early intervention will inhibit or diminish the cas-
cade effect, which is seen when several risk factors over
time influence an individual’s development. This may
be true not only for individuals who are born with fa-
milial high-risk but for people in general [44–47].
International studies on early preventive interventions
There are a few papers investigating the overall effect of
an early, preventive approach, but in general effect sizes
are small and there is still a lack of knowledge of many as-
pects [47, 48]. The Canadian study Families Overcoming
Risks and Building Opportunities for Well-Being (FOR-
BOW) led by Prof. Uher aims at providing an intervention
in the form of cognitive therapy and psychoeducation for
families with an SMI of any kind, but no results are avail-
able yet [29]. The idea is that the intervention is “low-bur-
den, low-risk,” i.e., not risky for the participants, as, for
example, medication could be, and it is directed against a
concrete and currently existing problem or situation that
it seems relevant to alleviate or solve for the family here
and now. Other initiatives [5] emphasize the importance
of parental skills training and support, psychoeducation,
reducing the effects of cognitive disabilities, and providing
practical, financial, and legal assistance.
Development of intervention and pilot testing
Based on the above mentioned evidence from the
existing literature combined with clinical experience
from the Danish High-Risk and Resilience Study VIA
7 [31, 49] (conducted by the last author) and results
from qualitative studies including focus group inter-
views by our own research group, we have proposed a
model for a specialized intervention for this specific
group of children. Based on this model, a manual for
the intervention was developed and pilot tested by the
intervention team in the pilot phase of the study. The
pilot study consists of two volunteer families, who
were included 5 months prior to the start of the study
period and who agreed to give feedback to the team
during the 18 months of the intervention.
Methods/design
This paper was written in line with the explanation and
elaborations relating to the guidance for protocols of clin-
ical trials in the 2013 SPIRIT guidelines (Standard Protocol
Items: Recommendations for Interventional Trials). The
SPIRIT figure (schedule of enrolment, interventions, and
assessments; Fig. 2), SPIRIT checklist (Additional file 1),
and the World Health Organization Trial Registration Data
Set (Additional file 2) were used.
Trial design
The VIA Family study is a two-armed parallel-group
randomized clinical trial testing for superiority of the
VIA Family group. The treatment allocation ratio is 1:1,
stratified exclusively by diagnostic group. The allocation
will be executed in a preset concealed block size order.
Objectives
The main objective of the trial is to test the VIA Family
intervention against treatment as usual (TAU). Cur-
rently, there is no specific treatment or support for fa-
milial high-risk children born to parents with an SMI
in Denmark.
Research question and hypothesis
The research question for this project is
 to investigate the effect of VIA Family, a
multidisciplinary and family-based intervention for
children born to a parent with an SMI, with a series
of preset outcome measures
The hypothesis is that by providing such children and
their families with an integrated, multidisciplinary, special-
ized, non-stigmatizing, and family-based intervention, it
will be possible
 to improve the child’s daily functioning, including a
reduction in the number of days absent from school
 to reduce the magnitude of the child’s mental
problems and symptoms of psychopathology
 to improve the general functioning of the family
 to relieve the total burden experienced by family
members and increase well-being
Over a longer perspective (5–10 years), we hypothesize
that VIA Family will:
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 reduce the prevalence and severity of mental illness
among the children
 enable parents to develop sufficient parenting skills
to reduce the possibility that their children will be
referred to institutional upbringing or foster care
Participants, interventions, and outcomes
Study setting
The VIA Family study is a close collaboration between the
Child and Adolescent Mental Health Center, Capital Re-
gion of Denmark, the Adult Mental Health Center
Copenhagen, Capital Region of Denmark, and the local
social services. Families are recruited from the municipal-
ities of Frederiksberg and Copenhagen. The interven-
tion sessions are held in a single center in Copenhagen in
a building away from all hospitals and in a different loca-
tion from the research team doing the assessment at base-
line and follow-up.
Eligibility criteria
The inclusion criteria are:
1. Families in the Frederiksberg or Copenhagen
municipalities who have at least one child aged
6–12. Families living in Frederiksberg are
prioritized. Further, at least one of the parents
must have a diagnosis of an SMI, which is defined
as schizophrenia spectrum disorder (ICD-10
codes F20, F21, F22, or F25, or ICD-8 codes 295,
297, 298.29, 298.39, 298.89, 298.99, or 301.83),
bipolar affective disorder (ICD-10 codes F30 or F31
or ICD-8 codes 296.19 or 296.39), or recurrent
moderate or severe depression (ICD-10 codes F 33.1,
F33.2, or F 33.3 or ICD-8 codes: 296.0, 298.0 or 300.4).
The diagnoses will be confirmed by the diagnostic
interview Schedules for Clinical Assessment in
Neuropsychiatry (SCAN) [50] at baseline.
2. For those recruited from the register sample, the
parent with an SMI diagnosis must have had at
least one in- or outpatient contact with the mental
health system within the lifetime of the child.
The exclusion criteria are:
1. Parents who do not speak and understand enough
Danish to be able to give informed consent for their
own participation and for the child’s participation.
2. If all family members are currently engaged in an
intensive family intervention program addressing
parental functioning and child development.
Criteria for discontinuing the intervention
If a family withdraws informed consent, they will be ex-
cluded from the study. All participants will still be asked
to participate in the follow-up interviews.
VIA Family intervention
The families, who by randomization are assigned to a VIA
Family team, are offered contact with a specialized multi-
disciplinary team. This team’s competences include know-
ledge and experience of the mental health system and
municipality social services, allowing them to achieve a
high degree of cross sectional synergy to meet the families’
Fig. 1 Model for multidisciplinary resources in the team
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needs as much as possible (Fig. 1). A team consists of five
members:
 a child and adolescent psychiatrist or physician who
has experience with providingchild and adolescent
mental health services
 a psychologist who has experience with providing
child and adolescent mental health services
 a nurse with clinical experiences from adult mental
health services
 a social worker who has worked with families in the
municipality
 a family counsellor or family therapist who has
worked with children in the municipality
The trial is a pragmatic trial, since we know that the
target families’ needs and problems are very diverse
and will vary over time. During the first two meetings,
two team members will collaborate with the family in
trying to uncover what kind of problems or unmet
needs the child or the family may experience. In co-
operation with the family, a problem-solving plan will
be produced that focuses on the issues that the family
has described. VIA Family is based on a series of basic
elements and a number of additional options can be
included if they are suitable for the family’s subjective
preferences.
The basic elements in VIA Family are:
 Case manager. A case manager will be designated
for the whole family. They will be easily accessible
and can offer home visits if relevant. The case
manager can help to coordinate appointments, will
participate in meetings, and will give information
and advice concerning possible support from the
municipality. The case manager is generally available
for the family for questions, worries, or problems of
any kind and will guide the family to the right
resources if the problem is outside the capacity of
the VIA Family team. The case manager will stay in
touch with the family when the family is not actively
working with the team, e.g., by sending text
messages or making phone calls.
 Psychoeducation. This focuses on what it is like to be
part of a family where one of the parents has an
SMI. This may also be relevant for those children
who do not live with the ill parent. The case
manager (often together with another team
member) will provide a specialized psychoeducational
course that is based on the family’s current situation
and relevant aspects of the parent’s illness status. The
course consists of approximately 6–8 sessions, which
include all family members. There is a planning phase
of 1–3 sessions with the parents followed by 1–3
sessions where the children are present. The course
ends with an evaluation session with the parents,
which includes considering the next issue for the
family to work with. The team has written and
collected relevant Danish-language material including
books and films that can be used.
 Parental training and support for the parenting role.
The parents are offered parental training based on
the evidence-based Positive Parenting Program
(Triple P) [51–53], with intensity and content
according to their specific needs. Triple P is a
multilevel program, meaning that the intensity,
content, and administration of the program can be
adapted to each family’s specific situation. It starts
at a less intensive, general level and can then be
unfolded to a more intensive level if needed or if
needs change. There are highly specific modules
for specific target groups and families and for
specific problems.
 Safety plan and mapping the social network and the
social resources of the family. The safety plan can be
used by any family member in an unexpected
situation or an acute crisis, e.g., if the family’s plans
and routines are not being followed due to the ill
parent’s sudden need for psychiatric first aid or
hospitalization. The safety plan addresses issues such
as who the family members can contact, what to tell
the children, and who should take care of them in
an acute crisis. It can include resources from the
municipality, possibly as a strategy to prevent an
acute situation. For the ill parent, meetings about
the parent’s mental state can be arranged within a
short time (e.g., if there are early signs of
exacerbation). Supportive meetings for the other
parent are also provided, since being the closest
relative can be demanding.
Other additional treatment options offered by the VIA
Family team
If needed, the team can offer the following treatment el-
ements facilitated by the case manager:
 Specialized treatment for the child’s (transient or
sub-threshold) mental problems or disturbances. This
can include anxiety, obsessive–compulsive disorder,
tics, or attention problems. The child and adolescent
psychologist and the child and adolescent psychiatrist
in the team can provide cognitive therapy or
psychoeducation according to Danish national
guidelines for treatment (from the Danish Ministry of
Health), and also specific cognitive therapy, e.g., for
children who have had psychotic-like experiences.
 Treatment groups for children, parents, and relatives.
The children will be offered a group course of 6–10
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meetings with 6–8 other children in a similar
situation. Together with a group therapist, they will
have the opportunity to talk openly about their
thoughts, experiences, and worries, and they can ask
questions and listen to the other children’s coping
strategies. The parents can simultaneously
participate in groups for relatives and parents with a
mental illness (parent café), where presentations
about relevant topics and networking between the
participants will be the main content. Treatment
groups are either facilitated by the VIA Family team
or by an external partner, to whom the families will
be directly referred, if they prefer.
 Counselling and guidance regarding financial, social,
or practical support from the municipality. This may
make it possible for the child to attend some kind of
leisure activity, like sports, the scouts, or music. The
financial support may pay any extra costs due to
child-related problems (e.g., washing and nappies for
a child with enuresis, which is very common). The
social support may be a supportive adult who can
build an independent relationship with the child
while also giving the parent a break. The case
manager will assist the family in the application
process, maybe assisted by the social worker in the
team. The municipality will make the final decision
regarding any request for support.
 Information about or supervision by institutions and
schools. This may be about the parent’s mental
illness or possible mental problems that the child
might have, if the parents agree.
 Optimization of the ill parent’s treatment and
lifestyle. This will be done in close collaboration with
the Adult Mental Health Center. Dialogues focusing
on the parenting role in relation to a recovery
process could be offered by the case manager.
 Fast track to mental health services. The Adult
Mental Health Center at Frederiksberg will offer all
families in the VIA Family group a fast track for acute
psychiatric assessments, which the case manager can
refer to whenever relevant. The Child and Adolescent
Mental Health Center will also offer a fast track for
any acute child psychiatric situation and will provide
supervision for more complicated cases concerning
the child’s mental health problems or any detected
need for further examination and diagnosing.
 Other help. Whenever possible, the team will also
try to help and assist the family with other matters
that are relevant for their well-being and everyday
functioning. It can help them to find the right re-
sources needed to solve a problem.
The sequence of engaging in the various elements is:
introduction (1–2 sessions), life line and history with
both parents (2–4 sessions), psychoeducational course
(6–8 sessions), Triple P (3–10 sessions), and groups for
both children and parents (8 sessions), followed by a
flexible period of up to 16 months of intervention with
individual or family meetings, evaluation, termination,
and transition to TAU.
The VIA Family team is not based in a hospital. The
building has a very non-clinical atmosphere, which is
family and child friendly. It can accommodate meetings
and confidential conversations and it has a room for
group sessions and educational courses. The surround-
ings are suitable for families with small children too. A
small selection of psychoeducational literature, books,
and folders are available for free.
Monitoring intervention fidelity
To ensure treatment fidelity, intervention team members
are all trained and supervised in treatment delivery and
the intervention is regularly monitored by the principal
investigators of the study group.
The VIA Family intervention is a specialized inter-
vention consisting of different treatment elements,
which are offered to all families. Each family will re-
ceive an individual package containing different ele-
ments and doses of the intervention. To measure
treatment fidelity, the intervention team will register
every single element of treatment given to a family for
later analyses (e.g., how many hours of psychoeducation
and which members of the family participated, number
of contacts, number of meetings etc.) in the data entry
system Research Electronic Data Capture (REDCap)
[54]. To ensure some degree of consistency for the VIA
Family intervention and to differentiate the experimen-
tal treatment from TAU, some criteria for minimum
participation in the VIA Family group have been de-
fined: (1) a minimum of 15 contacts with the case man-
ager (at least two contacts with personal attendance),
(2) at least one session of psychoeducation, (3) one ses-
sion to map the safety plan for the family, and (4) one
session to address parental training.
Treatment as usual
The families who by randomization are assigned to TAU
will continue to receive the same kind of help and support
as they did before entering the study. TAU is defined as
any kind of help and support focusing on high-risk chil-
dren and parental mental illness. At present, the munici-
palities and the mental health services do not offer any
kind of family-focused intervention addressing parental
mental illness that can be compared to the VIA Family
program. Moreover, the VIA Family team will work only
with the families randomized to VIA Family, thus contam-
ination from TAU to the VIA Family intervention will be
very limited. We expect a variation in TAU, as some of the
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families who are invited to participate will not be involved
with the municipality or the mental health system, while
other families are.
After the baseline assessment and before randomization,
all families (TAU and VIA Family) will receive a brief
phone call offering a standardized guide to the psycho-
social help and support for high-risk children and their
families available within the municipalities (Additional file
3). All families will also be offered verbal feedback on their
child’s performance and mental health status after the as-
sessment has been completed.
The families in the VIA Family intervention group
will have access to the same help and support available
within the municipalities and mental health services as
the TAU group, hence TAU is common for both
groups. However, we expect a difference in the usage
of TAU, because the case manager in the VIA Family
intervention group will help the families to access the
relevant services in the community. Moreover, some
of the services available within TAU and the interven-
tion (e.g., child support groups) have limited capacity
and access for participation within TAU but are of-
fered to all families in the VIA Family group. Data on
each child’s service use and on municipality involve-
ment and support for the whole family will be regis-
tered for both groups using information from the
municipality and by asking the families at baseline and
at the 9- and 18-month follow-ups.
During the trial, all forms of intervention and con-
comitant care are allowed except for participation in any
kind of ongoing and intensive family intervention pro-
gram addressing parental functioning and child develop-
ment involving all family members.
Outcomes
All outcome measures are listed in Fig. 2 for the 18-month
follow up. The children can later be traced uniquely in the
Danish registers, and information on e.g., the need for sup-
portive efforts, placement out of home, and termination of
elementary schooling can be investigated.
The selection of assessment instruments for the inter-
vention outcomes is based upon results from the Danish
High Risk and Resilience Study VIA 7 (conducted by the
last author [49]), and focus group interviews conducted
prior to the study with parents with schizophrenia and
bipolar disorder who participated in the VIA 7 study.
The same study confirmed that the instruments are rele-
vant and acceptable for families to complete.
Primary outcome The primary outcome is the change in
the estimate of the child’s general functioning, as mea-
sured by the current score on the Children’s Global As-
sessment Scale (CGAS) [55]. It is an estimate of the child’s
lowest level of functioning within the previous month.
CGAS will be measured at baseline and after 18 months
of the intervention. CGAS is a scale from 1 to 100 (the
higher score, the better the function), which is included in
the diagnostic interview Kiddie Schedule for Affective
Disorders and Schizophrenia (Present and Lifetime;
K-SADS-PL) [56]. The K-SADS-PL interview is done sep-
arately with the parent and the child, and covers all kinds
of mental or psychiatric problems that a child can have. It
also concerns the child’s daily level of functioning in the
family, in school, and during leisure time, which is the
basis of setting the CGAS score. CGAS is often used in re-
search and considers all available information. It has been
shown to have high validity and acceptable interrater
reliability [57]. It is a dimensional and detailed meas-
urement that accommodates that a given diagnosis
(e.g., attention deficit hyperactivity disorder) may have
a very different impact on the functioning of different
children. The CGAS score will be rated by a group of
trained and blinded clinicians with experience in child
and adolescent mental health services and experience
and training in the use of CGAS.
Secondary outcomes for the child
 Change in extent of psychopathology.
Psychopathology is measured by the Child Behavior
Checklist (CBCL) [58] after 18 months. The CBCL
is a questionnaire with 113 items that is given to the
parent. A score of 0 indicates that the child almost
never displays the behavior (e.g., being impulsive), a
1 indicates that the behavior is sometimes present,
and 2 that the behavior is observed often or always.
A maximum (but not realistic score) is 226. Clinical
cases, such as e.g., autism or attention deficit
hyperactivity disorder, score approximately 60 on
the CBCL scale. If the parents agree, the child's
main teacher/pedagogue will also be asked to fill in
the Teachers Report Form (same questions as the
CBCL). The CBCL is very well validated and is
widely used. It has the advantage of being dimensional
and has been shown to have very good correlations
with clinical diagnoses in numerous studies (http://
www.aseba.org/ordering/reliabilityvalidity.html).
Danish norms are available [59, 60].
 Change in number of days absent from school within
the last 6 months. This is an objective proxy
measure for the child’s well-being and family
function. It assumes that children in families with
poor functioning have a higher frequency of absence
from school due to lack of support and structure in
everyday routines, or due to more frequent somatic
complaints resulting in the child staying home from
school. It is mandatory for schools to report to the
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Fig. 2 (See legend on next page.)
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municipality days of absence for all pupils. Data will
be collected for the 18 months of the intervention
and changes will be analyzed.
Secondary outcomes for the family
 Evaluation of family functioning. This is assessed
with the Family Assessment Device (FAD) [61].
FAD is a thorough questionnaire with 60 items
based on a comprehensive sociological theory
about the different functions of a family. It is
completed by the parents or the actual caregivers
in the family. It will be used at baseline and after
18 months.
 Level of stimulation and support in the home.
This is evaluated by the Home Observation for
Measurement of the Environment (HOME) [62],
which is a semi-structured interview that can be
done only in the home with both the child and the
parent present. HOME is a continuous scale A score
under the predefined cut-off indicates that there
may be problems in the family.
Sample size
We used G*Power to calculate the sample size and
power of the study [63, 64]. We assumed that the treat-
ment and control groups were equal in size with the
same standard deviation (SD). The SD for the sample
size calculation was obtained from previous studies [30]
and from a cross-national reliability study [65].
 Primary outcome CGAS. If the intervention results
in an increase of the CGAS score of 10 points
(e.g., from 55 to 65, SD = 13), which is a realistic
estimate, we will have a high effect size. Power
calculations show that by including 37 children in
each group, we will be able to measure a difference
of 10 points on the CGAS score between the two
groups with a power of 0.90.
 Secondary outcome CBCL. If the intervention
reduces the total problem score on CBCL by 10
points (from 28 to 18, SD =15), which will be
clinically very relevant and realistic, we will have an
effect size of 0.66. Power calculations show that with
37 in each group, we will be able to detect a
difference between the two groups of 10 points in
the CBCL with a power of 0.80.
 Secondary outcome FAD. In a previous study with a
similar psychiatric population, the FAD general
functioning score was normally distributed with SD
= 0.51 (scale: 1–4, mean: 2.27) [66]. If the true
difference between the mean of the VIA Family
group and the mean in the TAU group at the
18-month follow-up is 0.4, we will need to study
35 families in each treatment group. Therefore, we
need a total of 70 families to be able to reject the
null hypothesis that the population means of the VIA
Family and TAU groups are equal with probability
(power) 0.90. The probability of a type I error
associated with this test of this null hypothesis is 0.05.
Recruitment
Method for recruitment in the study A list of eligible
participants will be drawn from the Danish Psychiatric
Central Register and the Central Person Register and
will, together with those referred directly from the in- or
outpatient clinics in the Mental Health Center of
Copenhagen, form the group of potential participants.
At least 100 families will be invited to participate
(Fig. 3). Data from the Danish registries show that a suffi-
cient number of participants can be found within the
catchment area of the trial, and that recruiting 100 fam-
ilies is realistic even if some potential participants decline.
Eligible parents and families will receive a letter and an
e-mail in their personal inbox, which is used for public
communications of all kinds in Denmark. They will re-
ceive a folder briefly describing the project and an invita-
tion to participate in the study. After the initial mail, the
research team will invite all families by phone to an infor-
mation meeting about the study. Moreover, parents who
(See figure on previous page.)
Fig. 2 Schedule of enrolment, interventions, and assessments (SPIRIT Figure). *Clinical rating, **semi-structured interview, ***self-report on use of
treatment and intervention facilities in private and public institutions (by any family member) 1 Days of absence from school (registry, parents
report, and teachers report). 2 Neurocognitive tests: RIST; Wechsler Intelligence Scale for Children, 4th Edition (Coding); Rey Complex Figure Test and
Recognition Trial; and Test of Memory and Learning, 2nd Edition (Memory of Stories). 3 Clinical Rating: TOF is in ASEBA. 4 CBCL is in ASEBA. 5 TRF is in
ASEBA. ACES Adverse Childhood Experiences, ADHD-RS Attention Deficit Hyperactivity Disorder Rating Scale, ASEBA Achenbach System of Empirically
Based Assessment, BRIEF Behavior Rating Inventory of Executive Function, CALS Children’s Affective Lability Scale, CBCL Child Behavior Checklist, CGAS
Children’s Global Assessment Scale, CTS Childhood Trauma Screener, CYRM Child and Youth Resilience Measurement, ERC Emotion Regulation
Checklist, FAD Family Assessment Device, FMSS Five-Minute Speech Sample, HOME Home Observation for Measurement of the Environment, K-SADS-
PL Kiddie Schedule for Affective Disorders and Schizophrenia: Present and Lifetime, MACA Multidimensional Assessment of Caring Activities Checklist,
PAFAS Parenting and Family Adjustment Scale, PANOC Positive and Negative Outcomes of Caring Questionnaire, PS Parenting Scale, PSP Personal and
Social Performance Scale, PSS Parental Stress Scale, RIST Reynolds Intellectual Screening Test, SCAN Schedules for Clinical Assessment in Neuropsychiatry,
SDQ Strengths and Difficulties Questionnaire, SPS Social Provision Scale, SRS Social Responsiveness Scale, TAU-SR Treatment as Usual Self Report, TOF Test
Observation Forms
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fit the inclusion criteria can be directly referred to the
study from in- or outpatient clinics in the municipalities.
If there are children in the family who are not aged be-
tween 6 and 12, they are included in the activities of the
intervention, but the assessment prior to randomization
and at follow-up will involve only children within the
defined age group at baseline.
Procedure for recruitment and enrollment if parents
do not live together The ill parent does not need to live
with the other parent or with the child if the child lives
in the municipalities of Frederiksberg or Copenhagen. In
these cases and when the parents share custody of the
child, the first step is to ask the ill parent for permission
to invite the child and the other parent. Both parents do
not need to participate, but if there has been a divorce
or legal separation with shared custody of the child, both
parents need to give their informed consent for the
child’s participation in the project.
Allocation
Randomization is carried out by a member of the interven-
tion team situated away from the research assessors. The
team member assigns participants to interventions. The al-
location concealment mechanism is performed by a com-
puter algorithm saved in REDCap [54]. The randomization
process cannot be influenced by the person who makes the
randomization or any other person. The randomization se-
quence is set in a preset concealed block size order with an
allocation ratio 1:1. The randomization is stratified solely by
diagnostic group.
Blinding
Outcome assessors, data analysts, and researchers will
be blinded throughout the study, including during the
Fig. 3 CONSORT flowchart for participants in the VIA Family study. TAU treatment as usual
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statistical analysis. In addition, researchers are blinded
to block size and frequencies. It is not possible to blind
the participants nor those providing the intervention.
The VIA Family intervention takes place at a site away
from the assessors, data analysts, and researchers,
which combined with the minimal interaction and
communication between the intervention team and the
assessors, aims to minimize the risk of unblinding. If
unblinding occurs during the study, it will be registered
and another assessor will perform the outcome assess-
ment at the follow-up for the family whose treatment
allocation has been revealed.
In theory, no circumstances should necessitate unblind-
ing of the assessors or researchers, since all relevant infor-
mation and clinical evaluations will be available to the
research manager (AAET) and members of the interven-
tion team, who can intervene in an emergency.
Data collection, management, and analysis
Data collection methods
Families are assessed with a range of diagnostic inter-
views, neurocognitive tests, interviews, and question-
naires at baseline and at the 18-month follow-up (Fig. 2
and Table 1). The assessment at baseline takes approxi-
mately 8 h in total for a family of two adults and one
child. The 9-month follow-up consists of a mid-phase
telephone call by an independent research assistant.
This contact seeks to decrease the risk of attrition from
the study. Data will be collected from all participants
independently of compliance to treatment.
To ensure the high quality of data, all assessors are
certified in administering K-SADS-PL, SCAN, and
HOME and perform regular co-ratings of videotaped
interviews. Furthermore, assessors are trained in ad-
ministering the Personal and Social Performance Scale
(PSP) [67], and the CGAS and ratings are done in an
expert group setting. Only trained clinical psychologists
administer the neurocognitive tests. All diagnoses are
confirmed at clinical conferences with a child and ado-
lescent psychiatrist being present.
Data management
All data, including all personal information about poten-
tial and enrolled participants, are entered directly into
the data entry system REDCap [54] by the assessors on
site, except for a few neurocognitive tests that can only
be made on paper. Self-report surveys for adults are ei-
ther answered electronically on site or at home and in
rare cases on paper if need be (e.g., by families who do
not have access to the internet at home and wish to fill
out the surveys at home). The surveys answered on
paper are entered into the data entry system REDCap
using double data entry.
All surveys for children are read out to the child. The
reasons are (1) to ensure standard procedures are used,
(2) to minimize the risk of variance between assessors’
judgement of children’s ability to read for themselves, and
(3) to avoid having surveys read to younger children and
not to older ones.
Range checks for data values have been implemented
in the data entry systems in REDCap.
Statistical methods
All tests will be two-tailed. The primary outcome ana-
lysis will be by intention to treat. Multiple imputations
will be used to handle missing data (if any). The impu-
tations will be based on a linear regression model with
100 imputations and 20 iterations. Pooled analyses will
subsequently be used for our analysis. In the imput-
ation model, we will select possible variables if they are
independent predictors of the outcome or predictors of
missing values (P < 0.05 in a univariable model). Ana-
lysis of covariance (ANCOVA or MANOVA as appro-
priate) will be used to calculate any significant results
between the two groups, using the baseline value and
the sex of the child as stratification variables.
All distributions of continuous outcome variables will
be assessed for normality using a visual inspection of
histograms with a normal probability curve and Q–Q
plots. If a variable is not normally distributed, the vari-
able will be transformed (e.g., log or square root), and if
unsuccessful, a non-parametric test (e.g., the Wilcoxon–
Mann–Whitney test) will be used.
For dichotomous outcomes, we will perform multiple
logistic regressions with TAU as the reference and stratifi-
cation variables as covariates after having imputed missing
values (if any) using a logistic regression model. If the ex-
perimental groups are not significantly correlated to the
outcome (P > 0.05), no further analyses will be performed.
If we find a significant correlation, a model that is equiva-
lent to the approach for continuous variables will be used.
Sensitivity analyses will include an analysis of complete
cases, removal of outliers (defined as standardized resid-
uals greater than 3 standard deviations), a per protocol
analysis defining participants not having a single contact
as violating the protocol, and a second per protocol ana-
lysis including only participants attending at least 50% of
intended personal meetings in the VIA Family group.
The second per protocol analysis is likely to cause severe
selection bias, as the VIA Family group would include
the participants with the highest level of motivation.
Therefore, it is considered meaningful to report only
negative results from this analysis.
Monitoring
The study does not have a data monitoring committee.
All study participants randomized to VIA Family are
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monitored for harmful events by the intervention team
or, in cases of hospitalization, by their general practi-
tioner or a doctor from the Mental Health Center. If
necessary, the principal investigator will make the final
decision to terminate the trial. All study participants will
be asked to report voluntarily all adverse events or other
Table 1 Test battery
Instrument Name Domain Child Parent Teacher
CGAS [55] Daily functioning x x
HOME [62]* Home environment, level of stimulation, and support x x
K-SADS-PL, including
psychosis-like symptoms [56]
Diagnostic screening and psychopathology x x
FMSS [72] Parent–child relationship x
RIST [73] General intelligence x
Coding from WISC-IV [74] Processing speed x
RCFT [75] Visual memory x
TOMAL-II: Memory for Stories [76] Verbal memory x
This is me [77] Self esteem x
Kids-Screen [78] Quality of life x
CTS [79] Childhood trauma x
CYRM [80] Resilience x
MACA-YC18 + PANOC-YC20 [81] Over-responsibility and caretaking x
CALS [82] Affective lability x
CBCL [58] Psychopathology x
TRF [83] Psychopathology x
BRIEF [84] Executive functioning x x
ADHD-RS [85] Attention x x
SDQ [86] Daily functioning and psychopathology x x
SRS-2 [87] Social cognition x x
ERC [88] Emotion regulation x x
FAD [61] Family functioning x
PSS [89] Parental level of stress x
PAFAS [90] Parental and family functioning x
Parenting Scale [91] Parenting style x
SPS [92] Social network, adult x
ACES [93] Adverse life events, adult x
PSP [94] Daily functioning, adult x
Anamnesis Socioeconomic status, developmental milestones, adverse life events, school, and family relations x
SCAN interview,
including LifeChart [50]
Psychopathology in adults and course of illness in relation to child’s age x
Absence from school, child x x
CSQ [95] Client satisfaction x x
TOF [96] Psychopathology: clinical rating after 60 min. of neuropsychological testing x
ACES Adverse Childhood Experiences, ADHD-RS Attention Deficit Hyperactivity Disorder Rating Scale, BRIEF Behavior Rating Inventory of Executive Function, CALS
Children’s Affective Lability Scale, CBCL Child Behavior Checklist, CGAS Children’s Global Assessment Scale, CSQ Client Satisfaction Questionnaire, CTS Childhood
Trauma Screener, CYRM Child and Youth Resilience Measurement, ERC Emotion Regulation Checklist, FAD Family Assessment Device, FMSS Five-Minute Speech
Sample, HOME Home Observation for Measurement of the Environment, K-SADS-PL Kiddie Schedule for Affective Disorders and Schizophrenia (Present and Lifetime),
MACA-YC18 Multidimensional Assessment of Caring Activities Checklist for Young Carers 18 items, PAFAS Parenting and Family Adjustment Scale, PANOC-YC20 Positive
and Negative Outcomes of Caring Questionnaire for Young Carers 20 items, PSP Personal and Social performance Scale, PSS Parental Stress Scale, RCFT Rey Complex
Figure Test, RIST Reynolds Intellectual Screening Test, SCAN Schedules for Clinical Assessment in Neuropsychiatry, SDQ Strengths and Difficulties Questionnaire, SPS
Social Provision Scale, SRS Social Responsiveness Scale, TOF Test Observation Form, TOMAL-II Test of Memory and Learning, 2nd Edition, TRF Teachers Report Form,
WISC-IV Wechsler Intelligence Scale for Children, 4th Edition
*) For children living 50/50 with mother and father, the HOME interview will be made in both homes
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unintended effects of the trial at the 9-month and
18-month follow-ups. The study will be audited weekly by
the principal investigator group, who are not involved in
the day-to-day work of the study and are independent of
the sponsors.
Discussion
There is an urgent need for visionary strategies and
preventive interventions in mental health services. Cur-
rently, we do not have a specific approach for prevent-
ing mental illness in children who are born with a
well-documented familial-based increased risk. The
VIA Family study is an innovative study attempting to
investigate the effects of an early, family-based, flexible,
and multidisciplinary intervention for families with
children who are known to have a significantly in-
creased risk for developing a mental illness later in life.
Further, evidence from qualitative studies and experi-
ence from large clinical studies show that these families
often struggle with everyday problems to a much
greater extent than other families [5].
The intervention to be tested, VIA Family, is based on
both evidence from the existing literature and on the very
first results from another Danish study, the Danish
High-risk and Resilience Study VIA 7 [49], as well as on
clinical experience and information from focus group in-
terviews with mentally ill parents and their co-parents.
Evidence from the literature has demonstrated that the
vulnerability of these children is detectable at a very early
age [10, 19]. Research and clinical experience have docu-
mented the increased risk of trauma, adverse life experi-
ences, and sub-optimal living conditions, including
problems with parenting for the children, all factors that
we know increase the risk of later mental illness [22].
Qualitative analyses confirm that a multidisciplinary ap-
proach and close collaboration between different units
and sectors are essential and needed to meet these fam-
ilies’ unmet needs [68]. In this way, the prevention will
help to solve problems that exist here and now.
One of the theories behind the project is develop-
mental traumatology, which focuses on the severe im-
pact that any childhood trauma and adverse life events
may have on a child’s brain and mental development,
their cognitive and social functioning, their stress
regulation and reward mechanism etc. [69]. If we can
reduce the total load of these environmental risk fac-
tors and stimulate potential resilience mechanisms,
then hopefully we can reduce each child’s risk of fall-
ing ill or experiencing other negative life events.
We have also investigated the large body of literature on
resilience and how this can be strengthened in children.
Factors like secure attachments, a social network, being
part of a community, having positive experiences, and
finding meaning in life are mentioned as crucial factors
for individuals with a high degree of resilience [70, 71] .
Strengths
The intervention being offered to the families is very
intensive and flexible, and this should increase our
chances of getting conclusive results. It lasts for 18
months and aims to meet almost any kind of problem
that the families may struggle with. It is more intensive
than those in most other studies [36]. Moreover, 18
months is quite a long intervention period. The inter-
vention does not focus on illness and disabilities but
more on everyday life in a non-stigmatizing way and is,
thus, expected to be acceptable for most families. That
the intervention is more intensive and comprehensive
than those in other studies may be experienced in a
negative way by some. However, each element has been
chosen based on qualitative interviews and very recent
results from a Danish cohort study [30, 31]. No treat-
ment elements will be introduced before the family ap-
prove them and find them relevant and motivating.
By using comprehensive Danish registries, we will be
able to follow these children in the future and have long
term follow-up results, since some outcomes may be in
the distant future. The assessment battery is comprehen-
sive and covers several areas of interest with validated
tests. For many of the tests we have Danish norms.
The target groups of people with schizophrenia, bipo-
lar disorder, or major depression were chosen because
evidence of the genetic impact in these disorders is well
documented. However, from the child’s perspective, the
diagnoses may not matter very much. Instead, it is the
impact on the parent that is relevant. Parents with diag-
noses other than those included in our study may have
similar problems or behavior, e.g., negative symptoms,
like anhedonia, lack of energy, restlessness, and anxiety.
If the results of our study are positive, the next step will
be to include families where one of the parents has
other serious mental problems, e.g., parents with per-
sonality disorders or with multiple diagnoses or com-
plex co-morbidities including substance abuse, to test
the generalizability.
Limitations
We intend to include 100 families in the study, which,
based on the power calculation of our primary out-
comes, is a sufficient number of participants for the
study to show an effect of the intervention. However, it
may be that the intervention is effective at a lower al-
though still clinically relevant level, which would need
a larger sample size to be detected.
Moreover, the study design is limited by the absence
of data from the pilot phase of the study, which could
have contributed to the design and feasibility assessment
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of the intervention. Although experience from the pilot
testing of the intervention and the instruments for as-
sessment, as well as the feedback from the pilot families,
were included in the intervention and overall study de-
sign, this knowledge cannot contribute to the study of
its feasibility. Hence, this trial will provide data that can
be used as pilot data for the development of a revised
version of the intervention manual and for future studies
in this field.
Also, we include children from three different diagnostic
categories, although we believe from research evidence
that the children born to parents with schizophrenia are
the most vulnerable of the three. From the child’s point of
view, the diagnosis of the parent may not mean much in
terms of how the family is functioning on a daily level, al-
though the genetic impact may be milder for those born
to parents with affective disorders. In particular, recruit-
ment of families where one of the parents is suffering
from schizophrenia may be the most troublesome.
Another challenge in all intervention studies is how to
avoid attrition, especially from the control group. We
hope that the initial feedback from the researchers, the
9-month status contact, and the emphasis on the im-
portance of participating in research will keep the fam-
ilies in the study.
The intensive intervention may sound positive, but we
should be aware that this could also be experienced as
overwhelming or over-involving for some participants.
Due to this study’s pragmatic and flexible approach, we
will not be able to identify which of the treatment ele-
ments was the most effectual. Further, it may be a prob-
lem that 18 months of intervention is too short for the
relevant differences to be recognizable.
Trial status
The current protocol is Version 4, December 2018. Recruit-
ment will take place from September 2017 to March 2019.
Additional files
Additional file 1: Completed SPIRIT checklist. (DOC 127 kb)
Additional file 3: World Health Organization Trial Registration Data Set.
(DOCX 21 kb)
Additional file 2: Guide for all study participants on psychosocial help
and support. (DOCX 24 kb)
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